Reference : Rh D foeto-maternal alloimmunization prophylaxis with anti-D immunoglobulins reviewed...
Scientific journals : Article
Human health sciences : Reproductive medicine (gynecology, andrology, obstetrics)
Human health sciences : Hematology
http://hdl.handle.net/2268/15872
Rh D foeto-maternal alloimmunization prophylaxis with anti-D immunoglobulins reviewed in the era of foetal RHD genotyping.
English
Minon, J. M. [Centre Hospitalier Régionale de la Citadelle (Liège) - CHR CITADELLE > Biologie clinique > Immuno-Hématologie > >]
Gerard, Christiane mailto [Centre Hospitalier Universitaire de Liège - CHU > > Hématologie biologique et immuno hématologie >]
Schaaps, Jean-Pierre [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique CHR >]
Foidart, Jean-Michel mailto [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique CHR >]
2009
Acta Clinica Belgica
Acta Clinica Belgica
64
3
195-202
Yes (verified by ORBi)
0001-5512
Bruxelles
Belgique
[en] In Belgium, prevention of anti-D immunization is currently based on systematic postnatal prophylaxis associated with targeted antenatal injection in high-risk situations of foeto-maternal haemorrhage.The failures of prevention are mainly due to the non-respect of established guidelines for RhlG prophylaxis, and to spontaneous undetected foetal-maternal haemorrhages without any obvious cause during the third trimester of pregnancy. In order to reduce the rate of residual post-pregnancy anti-D immunization, several countries decided to associate the classical prophylaxis to a routine antenatal anti-D prophylaxis (RAADP) during the 28th or 29th week of gestation. Since a few years, the foetal RHD genotyping in maternal plasma enables us to limit the antenatal prophylaxis only to those D- women carrying a D+ foetus. This paper deals with: the advantages of an antenatal prevention in the light of non-invasive foetal RHD genotyping, the rules rendering prevention protocols efficient whatever the algorithm applied, and the recommended immuno-haematology follow-up of women who received RhlG.
http://hdl.handle.net/2268/15872

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Minon Rh D foeto-maternal 2009.pdfNo commentaryPublisher postprint1.09 MBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.